U.S. Markets close in 3 hrs 11 mins

Aethlon Medical, Inc. (AEMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6900+0.1400 (+9.03%)
As of 12:44PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.5500
Open1.6900
Bid1.6800 x 1100
Ask1.7000 x 4000
Day's Range1.6100 - 1.7200
52 Week Range0.7600 - 4.3400
Volume463,144
Avg. Volume547,855
Market Cap20.429M
Beta (5Y Monthly)0.31
PE Ratio (TTM)N/A
EPS (TTM)-0.7060
Earnings DateFeb 08, 2021 - Feb 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
  • Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
    PR Newswire

    Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer

    Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, announced today the appointment of Charles J. Fisher, Jr., M.D., as Chief Executive Officer, effective as of October 30, 2020. Dr. Fisher joined Aethlon as a member of Aethlon's Board of Directors and has served as Chairman of the Board since November 2017. Mr. Ed Broenniman replaced Dr. Fisher as the Chairman of the Board effective as of October 30, 2020. Dr. Fisher brings an impressive record of results in global, strategic and operational roles to Aethlon. Dr. Fisher succeeds Dr. Timothy Rodell, who will serve as a consultant to Aethlon during the transition.

  • AEMD: Oncology EFS Open For Enrollment
    Zacks Small Cap Research

    AEMD: Oncology EFS Open For Enrollment

    By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical Inc. (NASDAQ:AEMD), a medical technology company engaged in developing products to diagnose and treat diseases in oncology and viral diseases that are life and organ threatening and not addressed with already approved treatments, reported 2Q FY 2021 results last night and provided a business update. The company’s lead

  • Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update
    PR Newswire

    Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

    Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its second quarter ended September 30, 2020 and provided an update on recent developments.